Spruce Biosciences (SPRB) shares drop 21% in premarket trading following a $60 million public stock offering priced at $50 per share.
Importance Rank:
1
Spruce Biosciences (SPRB) shares drop 21% in premarket trading following a $60 million public stock offering priced at $50 per share.